Annual CFO
-$341.00 M
+$81.00 M+19.19%
31 December 2023
Summary:
LogicBio Therapeutics annual cash flow from operations is currently -$341.00 million, with the most recent change of +$81.00 million (+19.19%) on 31 December 2023. During the last 3 years, it has risen by +$610.00 million (+64.14%). LOGC annual CFO is now -333.56% below its all-time high of $146.00 million, reached on 31 December 2017.LOGC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.00 M
+$13.00 M+86.67%
01 September 2024
Summary:
LogicBio Therapeutics quarterly cash flow from operations is currently -$2.00 million, with the most recent change of +$13.00 million (+86.67%) on 01 September 2024. Over the past year, it has increased by +$73.00 million (+97.33%). LOGC quarterly CFO is now -100.32% below its all-time high of $625.00 million, reached on 30 June 2020.LOGC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$167.00 M
+$84.00 M+33.47%
01 September 2024
Summary:
LogicBio Therapeutics TTM cash flow from operations is currently -$167.00 million, with the most recent change of +$84.00 million (+33.47%) on 01 September 2024. Over the past year, it has increased by +$174.00 million (+51.03%). LOGC TTM CFO is now -135.22% below its all-time high of $474.21 million, reached on 30 June 2020.LOGC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LOGC Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +97.3% | +51.0% |
| 3 y3 years | +64.1% | +95.9% | +82.4% |
| 5 y5 years | -468.3% | +82.9% | -331.0% |
LOGC Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.1% | at high | +98.6% | at high | +82.4% |
| 5 y | 5 years | +64.1% | -100.3% | +99.6% | -135.2% | +84.2% | |
| alltime | all time | -333.6% | +64.1% | -100.3% | +99.6% | -135.2% | +84.2% |
LogicBio Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.00 M(-86.7%) | -$167.00 M(-33.5%) |
| June 2024 | - | -$15.00 M(-80.0%) | -$251.00 M(-22.5%) |
| Mar 2024 | - | -$75.00 M(0.0%) | -$324.00 M(-5.0%) |
| Dec 2023 | -$341.00 M(-19.2%) | -$75.00 M(-12.8%) | -$341.00 M(-9.1%) |
| Sept 2023 | - | -$86.00 M(-2.3%) | -$375.00 M(-3.6%) |
| June 2023 | - | -$88.00 M(-4.3%) | -$389.00 M(+5.7%) |
| Mar 2023 | - | -$92.00 M(-15.6%) | -$368.00 M(-12.8%) |
| Dec 2022 | -$422.00 M(-55.6%) | - | - |
| Dec 2022 | - | -$109.00 M(+9.0%) | -$422.00 M(+16.6%) |
| Sept 2022 | - | -$100.00 M(+49.3%) | -$362.00 M(-40.3%) |
| June 2022 | - | -$67.00 M(-54.1%) | -$606.00 M(-18.4%) |
| Mar 2022 | - | -$146.00 M(+198.0%) | -$743.00 M(-21.9%) |
| Dec 2021 | -$951.00 M | -$49.00 M(-85.8%) | -$951.00 M(+2.7%) |
| Sept 2021 | - | -$344.00 M(+68.6%) | -$926.00 M(-12.1%) |
| June 2021 | - | -$204.00 M(-42.4%) | -$1.05 B(+368.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$354.00 M(+1375.0%) | -$225.00 M(<-9900.0%) |
| Dec 2020 | $0.00(-100.0%) | -$24.00 M(-94.9%) | $0.00(-100.0%) |
| Sept 2020 | - | -$472.00 M(-175.5%) | $12.30 M(-97.4%) |
| June 2020 | - | $625.00 M(-584.5%) | $474.21 M(-397.3%) |
| Mar 2020 | - | -$129.00 M(+1002.4%) | -$159.52 M(+311.7%) |
| Dec 2019 | -$60.00 M(-36.2%) | -$11.70 M(+16.0%) | -$38.75 M(+22.3%) |
| Sept 2019 | - | -$10.09 M(+15.5%) | -$31.69 M(+22.3%) |
| June 2019 | - | -$8.73 M(+6.0%) | -$25.91 M(+27.4%) |
| Mar 2019 | - | -$8.23 M(+77.4%) | -$20.34 M(+33.3%) |
| Dec 2018 | -$94.00 M(-164.4%) | -$4.64 M(+7.6%) | -$15.27 M(+43.7%) |
| Sept 2018 | - | -$4.31 M(+36.3%) | -$10.63 M(+68.3%) |
| June 2018 | - | -$3.16 M(+0.3%) | -$6.32 M(+100.3%) |
| Mar 2018 | - | -$3.15 M | -$3.15 M |
| Dec 2017 | $146.00 M(-6262.9%) | - | - |
| Dec 2016 | -$2.37 M | - | - |
FAQ
- What is LogicBio Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for LogicBio Therapeutics?
- What is LogicBio Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for LogicBio Therapeutics?
- What is LogicBio Therapeutics quarterly CFO year-on-year change?
- What is LogicBio Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for LogicBio Therapeutics?
- What is LogicBio Therapeutics TTM CFO year-on-year change?
What is LogicBio Therapeutics annual cash flow from operations?
The current annual CFO of LOGC is -$341.00 M
What is the all time high annual CFO for LogicBio Therapeutics?
LogicBio Therapeutics all-time high annual cash flow from operations is $146.00 M
What is LogicBio Therapeutics quarterly cash flow from operations?
The current quarterly CFO of LOGC is -$2.00 M
What is the all time high quarterly CFO for LogicBio Therapeutics?
LogicBio Therapeutics all-time high quarterly cash flow from operations is $625.00 M
What is LogicBio Therapeutics quarterly CFO year-on-year change?
Over the past year, LOGC quarterly cash flow from operations has changed by +$73.00 M (+97.33%)
What is LogicBio Therapeutics TTM cash flow from operations?
The current TTM CFO of LOGC is -$167.00 M
What is the all time high TTM CFO for LogicBio Therapeutics?
LogicBio Therapeutics all-time high TTM cash flow from operations is $474.21 M
What is LogicBio Therapeutics TTM CFO year-on-year change?
Over the past year, LOGC TTM cash flow from operations has changed by +$174.00 M (+51.03%)